Sensei Biotherapeutics, Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On March 27, 2024, Erin Colgan notified Sensei Biotherapeutics, Inc. (the “Company”) of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgan’s resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.
Extracted from this filing and checked against the source text.
Erin Colgan resigned as Chief Financial Officer at Sensei Biotherapeutics, Inc..
On March 27, 2024, Erin Colgan notified Sensei Biotherapeutics, Inc. (the “Company”) of her resignation from all positions with the Company, including as Chief Financial Officer. Ms. Colgan’s resignation is voluntary and will be effective April 10, 2024, and was not related to any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.